T-Cypher Bio
Xiao-yan Pan has a diverse work experience in the field of scientific research and coordination. They started their career as a Research and Teaching Assistant at Shanghai Second Medical University in 2003 and worked in this role until 2008. From 2008 to 2012, Xiao-yan worked as a Research Technician at the University of Birmingham and Birmingham Children's Hospital. They then joined the University of Oxford as a Postdoctoral Scientist from 2011 to 2013. Following their time at Oxford, Xiao-yan worked at the University of Manchester as a PDRA (Postdoctoral Research Associate) from 2013 to 2014, and subsequently as a Research Associate and Trial Coordinator from 2014 to 2016. Their most recent experience includes working at Orbit Discovery as a Senior Scientist from 2016 to 2020, and currently, they hold the position of Senior Scientist at T-Cypher Bio since 2020.
Xiao-yan Pan completed a Bachelor of Medicine and Bachelor of Surgery (MBBS) degree in Medicine from Shanghai Second Medical University, from 1998 to 2003. Following this, from 2009 to 2013, Xiao-yan Pan pursued further education and obtained a Doctor of Philosophy (PhD) degree in Cancer Science from the University of Birmingham.
T-Cypher Bio
T-Cypher Bio is an early-stage biotechnology company. T-Cypher Bio we believe that TCR-based therapeutics have the potential to transform the treatment of solid tumors, as well as autoimmune, inflammatory, and infectious diseases. Yet challenges in the identification of therapeutically relevant targets and TCRs have limited the application of suchtherapies.T-Cypher’s integrated platform, D-Cypher, overcomes these challenges.